============================================================ TITLE: FDA AI Guidance and COA Validation in Clinical Trials | Signant Health TYPE: article VERSION: 1 VERSION_ID: 66b8ed99-5cf0-4a39-a875-b0294f243a8a GENERATED_AT: 2026-06-17T12:56:54.446Z SUMMARY: What does FDA's 2025 AI guidance mean for eCOA & COA validation? Signant experts explain the risk framework and what it means for your validation strategy. AUTHOR: Signant Health DATE PUBLISHED: April 8, 2026 DATE MODIFIED: May 4, 2026 READING TIME: 3 min WORD COUNT: 479 KEYWORDS: Signant Health SOURCE URL: https://signanthealth.com/resources/fda-ai-guidance-and-ecoa-validation-in-clinical-trials-signant-health ============================================================ KEY TAKEAWAYS: * Explore Our Content Back to Resource Hub White paper FDA AI Guidance and COA Validation: What Sponsors Need to Know Signant Health Apr 8, 2026 White paper Marcela Roy, MA | Bill Byrom, PhD | Helen Brooker, PhDThe bottom line: If you're using AI in your COA program, the FDA now has a framework for how it gets validated. Here's what that means for your team.The FDA's first guidance on using AI to support regulatory decision-making changes the rules for any sponsor using AI in clinical outcomes assessment. If your program relies on AI for missing data imputation, endpoint adjudication, or sensor-based measure derivation, you now have a formal validation framework to meet.Signant Health's scientific and regulatory experts explain what the guidance means in practice for COA methodology, including: How the FDA's two-dimensional risk framework applies to eCOA use cases Which AI applications fall inside vs. outside the scope of the guidance What "black box" AI means for your regulatory submissions How to build a credibility assessment strategy proportionate to your program's risk level What early FDA engagement looks like when AI influences your decision-making Have questions about how this framework applies to your program? Talk to our COA experts GET THE WHITE PAPER # FDA AI Guidance and COA Validation: What Sponsors Need to Know Apr 8, 2026 White paper Marcela Roy, MA | Bill Byrom, PhD | Helen Brooker, PhDThe bottom line: If you're using AI in your COA program, the FDA now has a framework for how it gets validated. Here's what that means for your team.The FDA's first guidance on using AI to support regulatory decision-making changes the rules for any sponsor using AI in clinical outcomes assessment. If your program relies on AI for missing data imputation, endpoint adjudication, or sensor-based measure derivation, you now have a formal validation framework to meet.Signant Health's scientific and regulatory experts explain what the guidance means in practice for COA methodology, including: How the FDA's two-dimensional risk framework applies to eCOA use cases Which AI applications fall inside vs. outside the scope of the guidance What "black box" AI means for your regulatory submissions How to build a credibility assessment strategy proportionate to your program's risk level What early FDA engagement looks like when AI influences your decision-making Have questions about how this framework applies to your program? Talk to our COA experts GET THE WHITE PAPER * How the FDA's two-dimensional risk framework applies to eCOA use cases * Which AI applications fall inside vs. outside the scope of the guidance * What "black box" AI means for your regulatory submissions * How to build a credibility assessment strategy proportionate to your program's risk level * What early FDA engagement looks like when AI influences your decision-making Have questions about how this framework applies to your program? Talk to our COA experts GET THE WHITE PAPER ## Explore Our Content Brochure eCOA Science Consulting for Regulatory-Ready Clinical Endpoints Article How to Make Translations Work for Everyone Infographic Getting Started with eCOA: How to Design and Validate a Custom Electronic Patient Diary ### eCOA Science Consulting for Regulatory-Ready Clinical Endpoints ### How to Make Translations Work for Everyone Infographic ### Getting Started with eCOA: How to Design and Validate a Custom Electronic Patient Diary ### Get notified on new marketing insights Here mention the benefits of subscribing ------------------------------------------------------------ ABOUT THIS CONTENT ------------------------------------------------------------ Source: https://signanthealth.com/resources/fda-ai-guidance-and-ecoa-validation-in-clinical-trials-signant-health Author: Signant Health Published: April 8, 2026 This content is provided for informational purposes. Please visit the original source for the most up-to-date information.